TSW
MRNA icon

Three Seasons Wealth’s Moderna MRNA Stock Holding History

Three Seasons Wealth’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8,016
Closed -$407K – 212
2026
Q1 		$407K Buy
+8,016
New +$374K 0.16% 132
2024
Q3 		– Sell
-3,821
Closed -$454K – 111
2024
Q2 		$454K Buy
+3,821
New +$484K 0.25% 65

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Three Seasons Wealth's MRNA Position: Q2 2026 in Review

Three Seasons Wealth sold out of Moderna (MRNA) in Q2 2026, closing a stake of 8,016 shares — an estimated $407K sold.

Three Seasons Wealth first reported a position in MRNA in Q2 2024 and held it in 2 quarters. The position peaked at $454K in Q2 2024. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Three Seasons Wealth reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
  • Three Seasons Wealth sold 8,016 Moderna shares in Q2 2026, an estimated $407K.
  • Three Seasons Wealth first reported a position in Moderna in Q2 2024 and held it in 2 quarters.
  • Three Seasons Wealth's Moderna position peaked at $454K in Q2 2024.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Three Seasons Wealth's 13F filing for Q2 2026, filed 13 Aug 2026.